13F Filings History of NEXTHERA CAPITAL LP

Latest 13F report
Q2 2019 - 14 Aug 2019
Value $
$120,064,000
Signature - Title
Daniel Malek - Managing Member/CEO
Location
New York, NY
Summary
This page shows a list of all the recent 13F filings made by NEXTHERA CAPITAL LP. Form 13F is required to be filed within 45 days of the end of a calendar quarter. NEXTHERA CAPITAL LP reported 23 stock holdings with total value $120,064,000 as of Q2 2019. Top holdings included ICPT, INSM, BOLD, NBIX, and SRPT.

Notify me when NEXTHERA CAPITAL LP files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q2 2019 23 $120,064,000 +$76,259,207 -$36,324,202 +$39,935,005 ICPT, INSM, BOLD, NBIX, SRPT 13F-HR 14 Aug 2019, 16:08
Q1 2019 24 $82,402,000 +$23,726,000 -$139,603,680 -$115,877,680 BOLD, HRTX, INSM, IMMU, BHC 13F-HR 15 May 2019, 16:06
Q4 2018 20 $151,773,000 +$72,807,084 -$255,739,915 -$182,932,831 NVS, HRTX, BOLD, IMMU, BHC 13F-HR 14 Feb 2019, 16:00
Q3 2018 50 $370,776,000 +$136,203,521 -$174,452,797 -$38,249,276 EXEL, AGN, IMMU, MYL, DOVA 13F-HR 14 Nov 2018, 16:06
Q2 2018 42 $426,594,000 +$163,283,880 -$147,019,051 +$16,264,829 AGN, IMMU, EXEL, DOVA, TSRO 13F-HR 14 Aug 2018, 16:09
Q1 2018 36 $406,638,000 +$229,990,280 -$111,732,284 +$118,257,996 AGN, BMY, BMRN, SHPG, INSM 13F-HR 15 May 2018, 16:17
Q4 2017 30 $283,877,000 +$182,317,231 -$133,387,904 +$48,929,327 AGN, SHPG, MYL, MRK, ABLX 13F-HR 14 Feb 2018, 18:08
Q3 2017 32 $226,553,000 +$122,353,484 -$93,103,215 +$29,250,269 SGEN, CLVSQ, GSK, SGMO, FGEN 13F-HR 14 Nov 2017, 16:20
Q2 2017 36 $185,470,000 +$70,654,976 -$36,136,738 +$34,518,238 SHPG, ALXN, GSK, CELG, PFE 13F-HR 14 Aug 2017, 16:40
Q1 2017 29 $147,234,000 +$65,849,175 -$81,325,134 -$15,475,959 PFE, SHPG, CELG, GSK, ALXN 13F-HR 15 May 2017, 16:37
Q4 2016 34 $153,249,000 +$102,115,646 -$69,538,057 +$32,577,589 SHPG, NVS, CELG, ALXN, PFE 13F-HR 14 Feb 2017, 17:00
Q3 2016 31 $128,004,000 +$42,162,645 -$40,685,648 +$1,476,997 PFE, GSK, SHPG, XLRN, SGEN 13F-HR 14 Nov 2016, 16:08
Q2 2016 35 $115,486,000 +$62,297,613 -$44,241,750 +$18,055,863 PFE, GSK, SHPG, SGEN, MYL 13F-HR 15 Aug 2016, 16:24
Q1 2016 31 $95,202,000 +$54,834,464 -$22,032,628 +$32,801,836 CELG, SHPG, PFE, AGN, BMY 13F-HR 13 May 2016, 11:33
Q4 2015 45 $70,492,000 $0 $0 $0 PFE, BMY, CELG, MRK, SGEN 13F-HR 16 Feb 2016, 10:25